<code id='C6842796EE'></code><style id='C6842796EE'></style>
    • <acronym id='C6842796EE'></acronym>
      <center id='C6842796EE'><center id='C6842796EE'><tfoot id='C6842796EE'></tfoot></center><abbr id='C6842796EE'><dir id='C6842796EE'><tfoot id='C6842796EE'></tfoot><noframes id='C6842796EE'>

    • <optgroup id='C6842796EE'><strike id='C6842796EE'><sup id='C6842796EE'></sup></strike><code id='C6842796EE'></code></optgroup>
        1. <b id='C6842796EE'><label id='C6842796EE'><select id='C6842796EE'><dt id='C6842796EE'><span id='C6842796EE'></span></dt></select></label></b><u id='C6842796EE'></u>
          <i id='C6842796EE'><strike id='C6842796EE'><tt id='C6842796EE'><pre id='C6842796EE'></pre></tt></strike></i>

          explore

          explore

          author:fashion    Page View:55728
          dose of methadone
          A dose of methadone Kevin D. Liles/AP

          The federal government is reforming methadone care for the first time in over two decades. But how far do the changes actually go?

          To many methadone clinics, the Biden administration’s recent refresh of the rules governing opioid treatment programs represents an unprecedented opportunity to offer care that is more compassionate and responsive to patients’ needs. To many patient advocates, however, it simply nibbles around the edges. 

          advertisement

          The reality is likely somewhere in between: It will depend, in large part, on whether state-level regulators embrace the changes, and whether individual clinics actually implement them. In reform-oriented states, and at patient-centered clinics, the new rules could make a world of difference for people seeking addiction treatment. 

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Duchenne breakthrough therapy leaves behind pioneering families
          Duchenne breakthrough therapy leaves behind pioneering families

          DuchennemusculardystrophyDr.EdwinP.Ewing,Jr./CDCPatFurlongwassittinginherhomeofficeinMiddletown,Ohio

          read more
          Readout Newsletter: Insmed, Asahi Kasei, Agios, Royalty Pharma
          Readout Newsletter: Insmed, Asahi Kasei, Agios, Royalty Pharma

          AdobeWanttostayontopofthescienceandpoliticsdrivingbiotechtoday? Signup togetourbiotechnewsletterinyo

          read more
          Trump demands the U.S. pay no more for drugs than other countries … again
          Trump demands the U.S. pay no more for drugs than other countries … again

          EthanMiller/GettyImagesWASHINGTON—FormerPresidentTrumpisbacktocampaigningfortyingMedicaredrugpricest

          read more

          Generative AI mines health records to identify patients’ social needs

          AdobeGenerativeAI’searliestapplicationsinmedicinehavelargelyfocusedoncuringnotpatients,buttheplagueo